Log on / register
Feedback | Support | My details
  Quick Search
Current Opinion in Drug Discovery & Development
BioMed Central
PubMed Central
PubMed
  Jump to article
 vol.
page no.

Current Opinion in Drug Discovery & Development

Home



Current Opinion in Drug Discovery & Development, Volume 12, Issue 4 (July 2009)        [more info]

 
Current Opinion in Drug Discovery & Development is published bimonthly and focuses on the chemical aspects of drug discovery and development.

Access to the full text or PDF of articles from Current Opinion in Drug Discovery & Development requires a subscription to the journal.


  previous issue

 



 

 

 


Patent alert
Reuters Current Awareness Analysts Thomson
Current Opinion in Drug Discovery and Development 2009, 12:435-439 (24June2009)
[PDF]


Web alert
MA Stidham
Current Opinion in Drug Discovery and Development 2009, 12:440-442 (24June2009)
[PDF]


Personalized medicine A paradigm for a sustainable pharmaceutical industry?
S Chackalamannil, MC Desai
Current Opinion in Drug Discovery and Development 2009, 12:443-445 (24June2009)
[PDF]


Recent progress in the discovery and development of negative allosteric modulators of mGluR5
CW Lindsley, KA Emmitte
Current Opinion in Drug Discovery and Development 2009, 12:446-457 (24June2009)
[PDF]


PDE10A inhibitors: An assessment of the current CNS drug discovery landscape
T Chappie, J Humphrey, F Menniti, C Schmidt
Current Opinion in Drug Discovery and Development 2009, 12:458-467 (24June2009)
[PDF]


Glycine transport inhibitors for the treatment of schizophrenia: Symptom and disease modification
DC Javitt
Current Opinion in Drug Discovery and Development 2009, 12:468-478 (24June2009)
[PDF]


Prospects for the development of fusion inhibitors to treat human respiratory syncytial virus infection
J Bonfanti, D Roymans
Current Opinion in Drug Discovery and Development 2009, 12:479-487 (24June2009)
[PDF]


The importance of drug-target residence time
R Zhang, F Monsma
Current Opinion in Drug Discovery and Development 2009, 12:488-496 (24June2009)
[PDF]


Physiologically based pharmacokinetic (PBPK) modeling and simulation: Applications in lead optimization
SA Peters, AL Ungell, H Dolgos
Current Opinion in Drug Discovery and Development 2009, 12:509-518 (24June2009)
[PDF]


GPR119 agonists: A promising new approach for the treatment of type 2 diabetes and related metabolic disorders
U Shah
Current Opinion in Drug Discovery and Development 2009, 12:519-532 (24June2009)
[PDF]


Is there a future for Aurora kinase inhibitors for anticancer therapy?
P Carpinelli, J Moll
Current Opinion in Drug Discovery and Development 2009, 12:533-542 (24June2009)
[PDF]


Erratum [Fungal biotransformations of cannabinoids: Potential for new effective drugs. CODDD (2009) 12(2):305-312. Correction: the structure of chrysanthenol that appears in Figures 3 and 4]
Current Opinion in Drug Discovery and Development 2009, 12:562 (24June2009)
[PDF]

 

 

  previous issue

 







© 1999-2009 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.